Genetic Studies of Early-onset Dementia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age35+
SponsorColumbia University
About this trial
The aim of this study is to identify genetic factors that contribute to risk and progression of early-onset dementia (loss of memory function before the age of 70 years) across all ethnic groups, including Alzheimer's Disease, mild cognitive impairment and other dementias.
Eligibility criteria
Qualifiers
35 years and older
Individuals experiencing memory concerns or diagnosed with dementia and their family members that are unrelated healthy controls without dementia.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Blood draw
- Neurocognitive testing
- Medical questionnaire
Treatment groups
1,000 Participants
are divided into 4 treatment groupsLocations
1Columbia University Irving Medical Center10032, New YorkNew York, United States
Sponsors and collaborators
Columbia University
Lead sponsor
University of Miami
Collaborator
National Institute on Aging (NIA)
Collaborator
Source ClinicalTrials.gov